Product NDC: | 0430-6202 |
Proprietary Name: | Femring |
Non Proprietary Name: | estradiol acetate |
Active Ingredient(s): | .1 mg/d & nbsp; estradiol acetate |
Administration Route(s): | VAGINAL |
Dosage Form(s): | RING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0430-6202 |
Labeler Name: | Warner Chilcott (US), LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021367 |
Marketing Category: | NDA |
Start Marketing Date: | 20030701 |
Package NDC: | 0430-6202-95 |
Package Description: | 1 POUCH in 1 CARTON (0430-6202-95) > 90 d in 1 POUCH |
NDC Code | 0430-6202-95 |
Proprietary Name | Femring |
Package Description | 1 POUCH in 1 CARTON (0430-6202-95) > 90 d in 1 POUCH |
Product NDC | 0430-6202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | estradiol acetate |
Dosage Form Name | RING |
Route Name | VAGINAL |
Start Marketing Date | 20030701 |
Marketing Category Name | NDA |
Labeler Name | Warner Chilcott (US), LLC |
Substance Name | ESTRADIOL ACETATE |
Strength Number | .1 |
Strength Unit | mg/d |
Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |